Duarte Ira: insider trades.
Duarte Ira reported 6 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 0 open-market purchases and 0 sales, across 1 company.
- Transactions
- 6
- Purchases (P)
- 0
- Sales (S)
- 0
- Companies
- 1
- Name as filed
- Duarte Ira
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Heron Therapeutics, Inc. /De/ (HRTX) | Officer · EVP, Chief Financial Officer | 6 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-07-31 | Heron Therapeutics, Inc. /De/ | M | 11,694 | — | 285,225 | Form 4 |
| 2026-07-31 | Heron Therapeutics, Inc. /De/ | F | 3,326 | $0.5 | 281,899 | Form 4 |
| 2026-07-30 | Heron Therapeutics, Inc. /De/ | F | 3,850 | $0.5 | 273,531 | Form 4 |
| 2026-07-30 | Heron Therapeutics, Inc. /De/ | M | 13,535 | — | 277,381 | Form 4 |
| 2026-07-19 | Heron Therapeutics, Inc. /De/ | M | 3,874 | — | 264,947 | Form 4 |
| 2026-07-19 | Heron Therapeutics, Inc. /De/ | F | 1,101 | $0.47 | 263,846 | Form 4 |
Questions
What stock did Duarte Ira buy or sell?
Duarte Ira reported 6 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 0 open-market purchases and 0 sales, across 1 company.
Is Duarte Ira the same person as other filers with this name?
This page covers SEC CIK 1488864 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/duarte-ira-1488864.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.